Safety of and Immune Response to a Prime-Boost Vaccine Regimen in HIV-Uninfected Vaccine-Naive Adults

NCT00820846 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

299

Enrollment

NIH

Sponsor class

Conditions

HIV Infections

Interventions

BIOLOGICAL: pGA2/JS7 DNA vaccine
BIOLOGICAL: Placebo
BIOLOGICAL: MVA/HIV62 vaccine

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)